Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Natl Compr Canc Netw. 2012 Jul 1;10(7):821-9.

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.

Author information

  • 1Stanford Cancer Institute, CA, USA.

Abstract

These NCCN Guidelines Insights highlight the important updates/changes specific to the management of metastatic breast cancer in the 2012 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer. These changes/updates include the issue of retesting of biomarkers (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2) on recurrent disease, new information regarding first-line combination endocrine therapy for metastatic disease, a new section on monitoring of patients with metastatic disease, and new information on endocrine therapy combined with an mTOR inhibitor as a subsequent therapeutic option.

PMID:
22773798
[PubMed - indexed for MEDLINE]
PMCID:
PMC3753191
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk